Dermatology · Aiea, HI
NPI
1073690152
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
99-128 Aiea Heights Dr, Suite 401
Aiea, HI, 96701
Phone (808) 488-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$125K
1,733 services
Medicare patients, 2024
463
Average age 75
Drug cost, 2024
$582K
1,966 prescriptions
Company payments, 2025
$79K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wayne H Fujita was code 99214 (office e&m - established), 678 times for 360 patients. In total Wayne H Fujita billed 1,733 services in 55 codes, and Medicare paid $125K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 678 | 360 | $90.75 | $62K |
| 17110 Destruction Skin Lesion | Office | 227 | 176 | $75.47 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 167 | 108 | $11.73 | $1,959 |
| 99204 Office E&M - New | Office | 151 | 151 | $115.27 | $17K |
| 17003 Destruction Skin Lesion | Office | 127 | 40 | $5.38 | $683 |
| 17000 Destruction Skin Lesion | Office | 84 | 59 | $38.26 | $3,214 |
| 99213 Office E&M - Established | Office | 32 | 31 | $66.93 | $2,142 |
| 10060 Skin | Office | 30 | 28 | $78.36 | $2,351 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 25 | 17 | $0.62 | $15.56 |
| 11900 Skin | Office | 22 | 17 | $31.92 | $702 |
By year: 2022 $97K for 1,109 services; 2023 $119K for 1,359 services; 2024 $125K for 1,733 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| Q0112 All potassium hydroxide (koh) preparations | 18 | 15 | $5.30 | $95.4 |
Medicare prescription drug claims, 2024
In 2024, the drug Wayne H Fujita prescribed most often to Medicare patients was Ammonium Lactate, with 398 prescriptions and refills. In total Wayne H Fujita wrote 1,966 Medicare prescriptions that cost $582K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ammonium Lactate Generic | 398 | 513 | 205 | $6,775 |
| Ketoconazole Generic | 293 | 322 | 146 | $3,524 |
| Tacrolimus Generic | 130 | 145 | 79 | $37K |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 83 | 86 | 50 | $2,164 |
| Mometasone Furoate Generic | 82 | 89 | 61 | $1,547 |
| Tretinoin Generic | 66 | 71 | 36 | $4,781 |
| Fluocinonide Generic | 63 | 66 | 36 | $3,837 |
| Imiquimod Generic | 56 | 72 | 47 | $1,698 |
| Triamcinolone Acetonide Generic | 56 | 61 | 45 | $393 |
| Fluorouracil Generic | 56 | 58 | 40 | $2,917 |
| Dupixent Pen Dupilumab | 51 | 52 | Under 11 | $190K |
| Ciclopirox Ciclopirox Olamine | 42 | 48 | 28 | $1,493 |
| Fluocinonide-E Fluocinonide/Emollient Base | 41 | 45 | 29 | $2,621 |
| Doxycycline Monohydrate Generic | 38 | 46 | 22 | $885 |
| Levocetirizine Dihydrochloride Generic | 36 | 74 | 13 | $1,253 |
Brand drugs: 158 claims; generic drugs: 1,808 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wayne H Fujita $79K ($79K in general payments such as food, travel and fees) from 20 companies. The largest payer was Pfizer Inc. with $23K.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 18 | $23K |
| LEO Pharma Inc. | 38 | $15K |
| Amgen Inc. AMGN | 25 | $14K |
| Abbvie Inc. ABBV | 47 | $8,101 |
| Galderma Laboratories, L.P. GALD.SW | 36 | $7,873 |
| E.R. Squibb & Sons, L.L.C. BMY | 27 | $7,425 |
| Genzyme Corporation SNY | 13 | $593 |
| Lilly USA, LLC LLY | 15 | $435 |
| Arcutis Biotherapeutics, Inc. ARQT | 29 | $422 |
| UCB, Inc. UCB.BR | 15 | $415 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.